Impact Pharmaceutical Services was acquired by Syner-G BioPharma Group (Syner-G), a leading provider of integrated pharmaceutical science and regulatory consulting services to pharmaceutical and biotechnology clients, in February of 2022. Founded in 2009, the company operates within the Health Care and Pharmaceutical industries. Although specific details about the headquarters, last investment, and last investment investors are not available, Impact Pharmaceutical Services' acquisition by Syner-G reflects a significant development in the consolidation and growth of pharmaceutical service providers within the industry. This acquisition may offer investors insights and opportunities in the evolving landscape of pharmaceutical consulting and regulatory services.
There is no investment information
No recent news or press coverage available for Impact Pharmaceutical Services.
We care about your data, and we'd love to use cookies make your experience better.
